0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Genetic and Immunohistochemical Analysis of Helicobacter pylori Phenotypes and p27 Expression in Adenocarcinoma Patients in Jordan

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Stomach (gastric) cancer is one of the most prevalent and deadly cancers worldwide and most gastric cancers are adenocarcinomas. Based on prior research, there is an association between Helicobacter pylori ( H. pylori) infection together with the frequency of duodenal ulcer, distal gastric adenocarcinoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and antral gastritis. Helicobacter pylori virulence and toxicity factors have been identified before that significantly influence the clinical outcomes of H. pylori infection and gastric adenocarcinoma. However, it remains unclear exactly how different strains of H. pylori affect gastric adenocarcinoma. Current research suggests this involves tumor suppressor genes, like p27 but also H. pylori toxic virulence proteins. Therefore, we quantified known H. pylori genotypes within adenocarcinoma patients to establish the prevalence of known toxins that include cytotoxin-associated gene A (c agA) as well as vacuolating cytotoxin A (v acA) within patients of variable adenocarcinoma diagnosis. This analysis used gastrectomy samples validated for DNA viability. The incidence of H. pylori in adenocarcinoma patients in Jordan was established to be 54.5% positive ( ureA gene positive) with c agA genotype occurrence at 57.1%, but also in this population study v acA gene ratios found to be 24.7%:22.1%:14.3%:14.3%. ( vacAs1:vacAs2:vacAm1:vacAm2). Using immunohistochemistry (IHC), we confirmed with statistical significance that p27 was dysregulated and suppressed, within nearly all H. pylori vacA genotypes. In addition, within 24.6% of H. pylori samples analyzed was a different bacterial genotype, and curiously that p27 protein expression was retained in 12% of tested adenocarcinoma H. pylori samples. This is suggestive that p27 could be used as a prognostic indicator but also that an unknown genotype could be contributing to the regulatory effects of p27 protein within this bacterial and cellular environment that may include other virulence factors and unknown immune system regulatory changes.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s44197-023-00099-z.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors

          According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. Nearly 2 million new cases and about 1 million deaths are expected in 2018. CRC incidence has been steadily rising worldwide, especially in developing countries that are adopting the “western” way of life. Obesity, sedentary lifestyle, red meat consumption, alcohol, and tobacco are considered the driving factors behind the growth of CRC. However, recent advances in early detection screenings and treatment options have reduced CRC mortality in developed nations, even in the face of growing incidence. Genetic testing and better family history documentation can enable those with a hereditary predisposition for the neoplasm to take preventive measures. Meanwhile, the general population can reduce their risk by lowering their red meat, alcohol, and tobacco consumption and raising their consumption of fibre, wholesome foods, and certain vitamins and minerals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cell cycle, CDKs and cancer: a changing paradigm.

            Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumour cells. However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells. Emerging evidence suggests that tumour cells may also require specific interphase CDKs for proliferation. Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ki-67: more than a proliferation marker.

              Ki-67 protein has been widely used as a proliferation marker for human tumor cells for decades. In recent studies, multiple molecular functions of this large protein have become better understood. Ki-67 has roles in both interphase and mitotic cells, and its cellular distribution dramatically changes during cell cycle progression. These localizations correlate with distinct functions. For example, during interphase, Ki-67 is required for normal cellular distribution of heterochromatin antigens and for the nucleolar association of heterochromatin. During mitosis, Ki-67 is essential for formation of the perichromosomal layer (PCL), a ribonucleoprotein sheath coating the condensed chromosomes. In this structure, Ki-67 acts to prevent aggregation of mitotic chromosomes. Here, we present an overview of functional roles of Ki-67 across the cell cycle and also describe recent experiments that clarify its role in regulating cell cycle progression in human cells.
                Bookmark

                Author and article information

                Contributors
                sashboul@just.edu.jo
                ahmadaliraqi88@yahoo.com
                yashboul@just.edu.jo
                info@biochem123.org
                matalkai@just.edu.jo
                Journal
                J Epidemiol Glob Health
                J Epidemiol Glob Health
                Journal of Epidemiology and Global Health
                Springer Netherlands (Dordrecht )
                2210-6006
                2210-6014
                18 April 2023
                18 April 2023
                June 2023
                : 13
                : 2
                : 212-225
                Affiliations
                [1 ]GRID grid.37553.37, ISNI 0000 0001 0097 5797, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, , Jordan University of Science and Technology (JUST), ; Irbid, 22110 Jordan
                [2 ]Biochem123Education, London, UK
                [3 ]GRID grid.37553.37, ISNI 0000 0001 0097 5797, Department of Pathology and Microbiology, Faculty of Medicine, , Jordan University of Science and Technology (JUST), ; Irbid, 22110 Jordan
                Author information
                http://orcid.org/0000-0001-9001-3232
                http://orcid.org/0000-0001-6548-9183
                http://orcid.org/0000-0001-5238-6943
                http://orcid.org/0000-0003-4999-2242
                Article
                99
                10.1007/s44197-023-00099-z
                10272050
                37071369
                75e65735-1bc9-48c1-abe5-ce4e80f46f69
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 21 March 2023
                : 4 April 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100019004, Deanship of Research, Jordan University of Science and Technology;
                Award ID: 20120158 (does not include publication fees)
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © Springer Nature B.V 2023

                formalin-fixed paraffin-embedded tissue blocks,gastric cancer,gastrectomy,helicobacterpylorivaca-caga,immunohistochemistry,p27

                Comments

                Comment on this article